Global Artificial Cardiac Valves Market Growth 2023-2029

Global Artificial Cardiac Valves Market Growth 2023-2029

LPI (LP Information)' newest research report, the “Artificial Cardiac Valves Industry Forecast” looks at past sales and reviews total world Artificial Cardiac Valves sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Cardiac Valves sales for 2023 through 2029. With Artificial Cardiac Valves sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Cardiac Valves industry.

This Insight Report provides a comprehensive analysis of the global Artificial Cardiac Valves landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Cardiac Valves portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Artificial Cardiac Valves market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Cardiac Valves and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Cardiac Valves.

The global Artificial Cardiac Valves market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Artificial Cardiac Valves is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Artificial Cardiac Valves is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Artificial Cardiac Valves is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Artificial Cardiac Valves players cover Boston Scientific, Abbott, Medtronic, Edwards Lifesciences, Abbott Laboratories, Symetis, LivaNova, CryoLife and Braile Biomedica, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Cardiac Valves market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Mechanical Heart Valves
Biological/Tissue Heart Valves
Transcatheter Heart Valves

Segmentation by application
Hospitals
Ambulatory Surgery Centres
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
Abbott
Medtronic
Edwards Lifesciences
Abbott Laboratories
Symetis
LivaNova
CryoLife
Braile Biomedica
Colibri Heart Valve
JenaValve Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Artificial Cardiac Valves market?

What factors are driving Artificial Cardiac Valves market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Artificial Cardiac Valves market opportunities vary by end market size?

How does Artificial Cardiac Valves break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.